Equillium (EQ) Share-based Compensation (2018 - 2026)
Equillium's (EQ) quarterly Share-based Compensation came in at $930000.0 in Q1 2026, up 49.76% year-on-year from $621000.0 in Q1 2025, and up 189.68% on a QoQ basis from -$1.0 million in Q4 2025.
Equillium (EQ) Share-based Compensation (2018 - 2026) Analysis & Trends
Equillium (EQ) has 9 years of Share-based Compensation data on file, last reported at $930000.0 in Q1 2026.
- On a quarterly basis, Share-based Compensation rose 49.76% year-over-year to $930000.0 in Q1 2026; TTM through Mar 2026 was $1.3 million, a 60.72% decrease from a year earlier, with the FY2025 full-year figure at $7.7 million, up 105.33% from the prior year.
- Share-based Compensation for Q1 2026 stood at $930000.0, up from -$1.0 million in the prior quarter.
- Over the last five years, Share-based Compensation for EQ reached as high as $8.4 million in Q3 2025 and fell as low as -$3.7 million in Q4 2022.
- Historically, Share-based Compensation has averaged $991176.5 across 5 years, with a median of $952000.0 in 2024.
- Across the five-year window, Share-based Compensation jumped 6505.56% in 2022 and slumped 226.31% in 2025, its largest moves.
- Year by year, Share-based Compensation stood at -$3.7 million in 2022, then jumped by 128.0% to $1.0 million in 2023, then slipped by 21.51% to $821000.0 in 2024, then slumped by 226.31% to -$1.0 million in 2025, then soared by 189.68% to $930000.0 in 2026.
- Per Business Quant data, the three most recent Share-based Compensation figures were $930000.0 in Q1 2026, -$1.0 million in Q4 2025, and $8.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 6.39 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 3.20 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9.26 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 166.40 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 257.40 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 87.30 Mn |
| 10 | Equillium | 242.14 Mn | 242.14 Mn | - | 930,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 930,000.00 |
| Mar 31, 2026 | 930,000.00 |
| Dec 31, 2025 | -1.04 Mn |
| Dec 31, 2025 | -1.04 Mn |
| Sep 30, 2025 | 8.40 Mn |
| Sep 30, 2025 | 8.40 Mn |
| Jun 30, 2025 | 2.70 Mn |
| Jun 30, 2025 | 2.70 Mn |
| Mar 31, 2025 | 621,000.00 |
| Mar 31, 2025 | 621,000.00 |
| Dec 31, 2024 | 821,000.00 |
| Dec 31, 2024 | 821,000.00 |
| Sep 30, 2024 | 1.01 Mn |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 952,000.00 |
| Jun 30, 2024 | 952,000.00 |
| Mar 31, 2024 | 972,000.00 |
| Mar 31, 2024 | 972,000.00 |
| Dec 31, 2023 | 1.05 Mn |
| Dec 31, 2023 | 1.05 Mn |